Cambrian BioPharma

Cambrian partners with exceptional scientists to bring new classes of medicines to patients in need, built around understanding the deep science of the biological drivers of aging, with the potential to both treat and prevent today’s deadliest diseases. The company’s approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve overall quality of life as we age. Their science targets the three key drivers of aging: molecular alterations, cellular dysfunction, and tissue degeneration. Cambrian isn’t a typical drug development company. They combine the knowledge sharing of a company-building VC with the long-term vision of a pharmaceutical company and the entrepreneurial spirit of a biotech startup. They currently have ten companies in their portfolio each with several shots on goal. The first drug to enter the clinic is an AMPK activator a daily oral medication for peripheral artery disease, that also provides the benefit of a day’s worth of exercise.


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.